1
/
of
1
Elabscience
SKU:PKSH033207
Recombinant Human VEGF-A/VEGF121 Protein (Active)
Recombinant Human VEGF-A/VEGF121 Protein (Active)
Regular price
$178.00 USD
Regular price
Sale price
$178.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Vascular Endothelial Growth Factor-A (VEGF-A)/VEGF121 Protein (Active), a cutting-edge product designed to revolutionize the field of biomedical research. This meticulously engineered protein offers unparalleled efficacy and potency, making it an indispensable tool for scientists and researchers alike.
Derived from advanced recombinant DNA technology, this VEGF-A/VEGF121 protein is meticulously synthesized to ensure utmost purity and activity. Its active form enables it to interact with specific receptors, thereby stimulating angiogenesis and promoting the growth of blood vessels. This unique attribute makes it an invaluable asset in various research applications, including but not limited to cancer research, tissue engineering, and regenerative medicine.
The Recombinant Human VEGF-A/VEGF121 Protein (Active) boasts exceptional stability and solubility, facilitating ease of use and ensuring consistent results. Its high bioactivity guarantees reliable and reproducible outcomes, empowering researchers to delve deeper into the intricate mechanisms underlying angiogenesis and vascular development.
Furthermore, this product adheres to the highest quality standards, undergoing rigorous quality control measures to ensure batch-to-batch consistency and reliability. Its exceptional purity, devoid of any contaminants or impurities, guarantees optimal performance and minimizes any potential interference in experimental outcomes.
In summary, the Recombinant Human VEGF-A/VEGF121 Protein (Active) represents a breakthrough in the realm of biomedical research. Its unrivaled efficacy, stability, and purity make it an indispensable tool for scientists seeking to unravel the complexities of angiogenesis and vascular development. With this product, researchers can confidently embark on groundbreaking studies, paving the way for advancements in various fields, including cancer therapeutics, tissue engineering, and regenerative medicine.
Derived from advanced recombinant DNA technology, this VEGF-A/VEGF121 protein is meticulously synthesized to ensure utmost purity and activity. Its active form enables it to interact with specific receptors, thereby stimulating angiogenesis and promoting the growth of blood vessels. This unique attribute makes it an invaluable asset in various research applications, including but not limited to cancer research, tissue engineering, and regenerative medicine.
The Recombinant Human VEGF-A/VEGF121 Protein (Active) boasts exceptional stability and solubility, facilitating ease of use and ensuring consistent results. Its high bioactivity guarantees reliable and reproducible outcomes, empowering researchers to delve deeper into the intricate mechanisms underlying angiogenesis and vascular development.
Furthermore, this product adheres to the highest quality standards, undergoing rigorous quality control measures to ensure batch-to-batch consistency and reliability. Its exceptional purity, devoid of any contaminants or impurities, guarantees optimal performance and minimizes any potential interference in experimental outcomes.
In summary, the Recombinant Human VEGF-A/VEGF121 Protein (Active) represents a breakthrough in the realm of biomedical research. Its unrivaled efficacy, stability, and purity make it an indispensable tool for scientists seeking to unravel the complexities of angiogenesis and vascular development. With this product, researchers can confidently embark on groundbreaking studies, paving the way for advancements in various fields, including cancer therapeutics, tissue engineering, and regenerative medicine.
Share
